Lumanity will be attending and presenting during the 2024 conference.
Panel Presentations:
“The Name of the Game”: Strategic synergies in biopharma dealmaking, M&A trends and alliance management – time for a rethink?
Monday, November 4, 2024
14:00, Location: Room K1
Panelists:
- Philippe Lopes-Fernandes, EVP Chief Business Officer, Ipsen
- Morten Graugaard Døssing, Partner, Novo Holdings
- Elena Cavalli, Head of Commercial and Enterprise Alliances, Business Development, Astellas Pharma
- Moderator: Ed Saltzman, Senior Strategic Advisor, Lumanity
Atossa Therapeutics and the Karolinska Institute: The SMART study: A Unique Swedish-American Collaboration to Prevent Breast Cancer
Monday, November 4, 2024
17:00, Location: Room K11
Panelists:
- Per Hall, Professor, Karolinska Institute
- Steven Quay, Chairman of the Board and CEO, Atossa Therapeutics
- Moderator: Ed Saltzman, Senior Strategic Advisor, Lumanity
“I’ve Been Waiting for You”: Rise of novel cardiometabolic therapies
Tuesday, November 5, 2024
17:00, Location: Room K2
Panelists:
- Peng Leong, CBO and Head of Brain Aging, BioAge
- Brett Haumann, Venture Partner, SV Health Investors LLP
- Birgit Steckel-Hamann, PhD, MSc, Senior Director – External Innovation Cardiometabolic Health, Eli Lilly & Company
- Moderator: Ed Saltzman, Senior Strategic Advisor, Lumanity
Schedule time to meet with us by reaching out to contact@lumanity.com.